Name | Title | Contact Details |
---|
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
The Future of Healthcare Nutex Health Inc. is a technology-enabled health management company with two divisions: Business Development Marketing Operations Coordination Legal Human Resources Accounting Billing & Collections Nutex Health Inc. is a techno...
United! International Laboratories is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Mulberry Grove is a Statham, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Innovatix is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.